A reanalysis of curvature in the dose response for cancer and modifications by age at exposure following radiotherapy for benign disease

. Author manuscript; available in PMC: 2014 Feb 1.

Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 Jun 9;85(2):451–459. doi: 10.1016/j.ijrobp.2012.04.029

Figure 1. Relative risk vs dose (with 95% CI) for various malignant endpoints, with fit of optimal linear and linear-exponential models. All use relevant average organ dose (stomach for all cancer, all other cancers).